Matches in SemOpenAlex for { <https://semopenalex.org/work/W3099692887> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W3099692887 abstract "Background: People with HIV(PWH) have a high risk of hypertension and hypertension-related cardiovascular diseases (CVD). Objectives: Given unique pathways contributing to hypertension among PWH, we sought to determine whether antihypertensive class was associated with CVD events in PWH. Methods: Among veterans with HIV and new onset hypertension (2000-2019), we used propensity score-matching with Cox regression to evaluate the risk of CVD events (ischemic heart disease, heart failure, stroke) or death by initial antihypertensive class. In supplementary analyses we used marginal structural modeling to account for time-updated antihypertensive class and confounding. Results: Among 8041 PWH with hypertension, 24% were initiated on angiotensin-converting enzyme inhibitor/angiotensin-receptor blocker (ACEi/ARB) monotherapy, 23% on thiazide/thiazide-like diuretic monotherapy, 13% on β-blocker monotherapy, and 11% on calcium channel blocker (CCB) monotherapy. Median (IQR) follow-up was 6.5 (3.2-10.5) years and 25% experienced a CVD event. In propensity score-matched analyses, β-blockers, but not CCBs or thiazide/thiazide-like diuretics, were associated with an increased risk of 1) CVD or death 2)incident CVD or death and 3)incident CVD compared with ACEs/ARBs (Incident CVD: HR [95% CI] β-blockers 1.90 [1.24, 2.89]; CCBs 1.02 [0.77, 1.34]; diuretics 1.06 [0.86,1.31]; Figure) . Similar risks were associated with β-blockers in time-updated analyses. In veterans without CKD, initial ACEi/ARB use carried a lower risk of incident heart failure compared with all other classes. Conclusions: We observed high rates of CVD events in PWH with hypertension, and a high prevalence of β-blocker use for initial hypertension management, even among those without indications. Our findings highlight the potential harm associated with β-blockers and the possible benefit associated with ACEI/ARBs for hypertension management in PWH." @default.
- W3099692887 created "2020-11-23" @default.
- W3099692887 creator A5005215114 @default.
- W3099692887 creator A5015886728 @default.
- W3099692887 creator A5022449367 @default.
- W3099692887 creator A5027098575 @default.
- W3099692887 creator A5047317486 @default.
- W3099692887 creator A5084279534 @default.
- W3099692887 creator A5091541557 @default.
- W3099692887 date "2020-11-17" @default.
- W3099692887 modified "2023-09-28" @default.
- W3099692887 title "Abstract 14337: Antihypertensive Class and Cardiovascular Outcomes in Patients With HIV and Hypertension" @default.
- W3099692887 doi "https://doi.org/10.1161/circ.142.suppl_3.14337" @default.
- W3099692887 hasPublicationYear "2020" @default.
- W3099692887 type Work @default.
- W3099692887 sameAs 3099692887 @default.
- W3099692887 citedByCount "0" @default.
- W3099692887 crossrefType "journal-article" @default.
- W3099692887 hasAuthorship W3099692887A5005215114 @default.
- W3099692887 hasAuthorship W3099692887A5015886728 @default.
- W3099692887 hasAuthorship W3099692887A5022449367 @default.
- W3099692887 hasAuthorship W3099692887A5027098575 @default.
- W3099692887 hasAuthorship W3099692887A5047317486 @default.
- W3099692887 hasAuthorship W3099692887A5084279534 @default.
- W3099692887 hasAuthorship W3099692887A5091541557 @default.
- W3099692887 hasConcept C126322002 @default.
- W3099692887 hasConcept C127413603 @default.
- W3099692887 hasConcept C164705383 @default.
- W3099692887 hasConcept C17923572 @default.
- W3099692887 hasConcept C2778198053 @default.
- W3099692887 hasConcept C2779918671 @default.
- W3099692887 hasConcept C2780437262 @default.
- W3099692887 hasConcept C2780645631 @default.
- W3099692887 hasConcept C50382708 @default.
- W3099692887 hasConcept C71924100 @default.
- W3099692887 hasConcept C77350462 @default.
- W3099692887 hasConcept C78519656 @default.
- W3099692887 hasConceptScore W3099692887C126322002 @default.
- W3099692887 hasConceptScore W3099692887C127413603 @default.
- W3099692887 hasConceptScore W3099692887C164705383 @default.
- W3099692887 hasConceptScore W3099692887C17923572 @default.
- W3099692887 hasConceptScore W3099692887C2778198053 @default.
- W3099692887 hasConceptScore W3099692887C2779918671 @default.
- W3099692887 hasConceptScore W3099692887C2780437262 @default.
- W3099692887 hasConceptScore W3099692887C2780645631 @default.
- W3099692887 hasConceptScore W3099692887C50382708 @default.
- W3099692887 hasConceptScore W3099692887C71924100 @default.
- W3099692887 hasConceptScore W3099692887C77350462 @default.
- W3099692887 hasConceptScore W3099692887C78519656 @default.
- W3099692887 hasIssue "Suppl_3" @default.
- W3099692887 hasLocation W30996928871 @default.
- W3099692887 hasOpenAccess W3099692887 @default.
- W3099692887 hasPrimaryLocation W30996928871 @default.
- W3099692887 hasRelatedWork W1579397961 @default.
- W3099692887 hasRelatedWork W162301260 @default.
- W3099692887 hasRelatedWork W2053109504 @default.
- W3099692887 hasRelatedWork W2157826609 @default.
- W3099692887 hasRelatedWork W2372076784 @default.
- W3099692887 hasRelatedWork W2408383318 @default.
- W3099692887 hasRelatedWork W2410035330 @default.
- W3099692887 hasRelatedWork W2584343805 @default.
- W3099692887 hasRelatedWork W2949240036 @default.
- W3099692887 hasRelatedWork W4229067986 @default.
- W3099692887 hasVolume "142" @default.
- W3099692887 isParatext "false" @default.
- W3099692887 isRetracted "false" @default.
- W3099692887 magId "3099692887" @default.
- W3099692887 workType "article" @default.